Clinical trials: Randomized-controlled Trial
- Condition Randomized-controlled Trial
- Funder type Industry (pharma, biotech, devices)
- Accepts healthy volunteers yes
Randomized Versus Placebo, Controlled
Effect of the Alpha-galacto-oligasaccharides on Weight Loss in Overweight or Moderately Obeses Adults : A Randomized Controlled Double Blinded Trial Versus Placebo
Clinical intervention on overweight or moderately obeses adults. The objective of this trial is to demonstrate the superior eficacy of Alphagos to placebo on weight loss during a low-calorie diet of 12 weeks.
- Conditions
- Randomized Versus Placebo, Controlled, Double Blind
- Trial name
- NCT02228746
- Testing
- Alpha-galacto-oligosaccharides
- Where
- France
- Volunteers
- 100 people, healthy volunteers welcome
- Sponsor
- Olygose